ACR Perspectives
View all perspectives
David Liew drdavidliew
2 years 5 months ago
For those of you playing along at home - the @RheumNow GCA/PMR panel's highlights #ACR21:
bari in GCA: https://t.co/QZhzQEt8GE
secukinumab in GCA:
https://t.co/OJQDBR5Hyy
8w PNL w TCZ in GCA:
https://t.co/ejnsVYeSgo
TCZ for PMR:
https://t.co/suWkQ5CgyP
- David Liew on Twitter: "Baricitinib for *relapsing* GCA (Th1+Th17) w a…
- David Liew on Twitter: "Secukinumab in GCA, phase 2 (TitAIN): I can…
- David Liew on Twitter: "How much PNL do you need with TCZ in GCA, to avoid…
- David Liew on Twitter: "It's all happening for biologic therapies in P…
Dr. Rachel Tate uptoTate
2 years 5 months ago
Burning question: How many nrAxSpA pts "progress" to AxSpA? Check out my video on abstract 0907 from #ACR21 #RheumNow
https://t.co/M78SrD25KP
Dr. John Cush RheumNow
2 years 5 months ago
Day 2 Report from ACR21
Highlight reports from Sunday, Day 2 at #ACR21 Convergence
https://t.co/Zo6Vw8mAsI https://t.co/nqxSP9euV8
Dr. John Cush RheumNow
2 years 5 months ago
Dr. Jack Cush, Dr. Aurelie Najam ( @AurelieRheumo) , Dr. Bella Mehta ( @bella_mehta) Dr. Yuz Yusof ( @Yuz6Yusof), Dr. Pedro Castillo ( @_Castillo_Pedro) and Dr. Richard Conway ( @RichardPAConway) discuss highlights from the first full day of the #ACR21.
https://t.co/eLrAzYvcMG https://t.co/c5gGfFK1KO
Dr. John Cush RheumNow
2 years 5 months ago
RA Risk in Cardiovascular Disease: Dr. Eric Dein ( @ericdeinmd ) discusses abstracts #0269 and #0271 presented at the #ACR21 annual meeting.
https://t.co/qSdfuqKbMI https://t.co/Lw1rGGF2Zt
Dr. John Cush RheumNow
2 years 5 months ago
Does RA Begin in the Gut? Dr. Jonathan Kay reviews abstract #0461 presented at the #ACR21 annual meeting.
https://t.co/Q2WrJ8XYUZ https://t.co/jLaczx9ya4
Dr. John Cush RheumNow
2 years 5 months ago
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow
2 years 5 months ago
Lupus Updates with Dr. Michelle Petri
https://t.co/4YZt4Pko4z https://t.co/MaXV5EXEVv
Dr. John Cush RheumNow
2 years 5 months ago
Infection or Disease Flare: What Tools Can Help Differentiate?
Dr. Olga Petryna ( @DrPetryna) shares studies presented at #ACR21.
https://t.co/EOwgjdCzUO https://t.co/bbwLfNq2cO
Dr. John Cush RheumNow
2 years 5 months ago
Evolution of Rheumatoid Arthritis: Arthur Kavanaugh
Dr. Arthur Kavanaugh reviews several RA-related studies presented at the #ACR21 annual meeting. https://t.co/LdeMH1k362
Md Yuzaiful Md Yusof Yuz6Yusof
2 years 5 months ago
Which achievable Target could reduce mortality by just over 50% in #lupus 🦋? Do watch my video on Treat to Target in SLE: Dr. Yuzaiful Yusof https://t.co/H8kgFW9H06 via @YouTube @RheumNow
Dr. John Cush RheumNow
2 years 5 months ago
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow
2 years 5 months ago
The PROOF Study in AxSpA: Dr. Sheila Reyes ( @RHEUMarampa ) discusses abstract #0363 presented at the #ACR21 annual meeting.
https://t.co/mkKakbYHKb https://t.co/dUhlolIvBR
Dr. John Cush RheumNow
2 years 5 months ago
Axial spondyloarthritis with psoriasis or psoriatic spondylitis
Dr. Antoni Chan ( @synovialjoints ) shares learnings from #ACR21.
https://t.co/ZH9IC2iViF https://t.co/nmq5PGzWJV
Poster Hall